Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis
Condition(s):Primary Sclerosing CholangitisLast Updated:March 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Primary Sclerosing CholangitisLast Updated:March 28, 2024Recruiting
Condition(s):Primary Sclerosing CholangitisLast Updated:January 30, 2020Completed
Condition(s):Primary Sclerosing CholangitisLast Updated:January 2, 2024Recruiting
Condition(s):Primary Sclerosing CholangitisLast Updated:October 1, 2018Completed
Condition(s):Primary Sclerosing CholangitisLast Updated:February 9, 2016Completed
Condition(s):Primary Sclerosing CholangitisLast Updated:August 4, 2010Completed
Condition(s):Primary Sclerosing CholangitisLast Updated:December 21, 2020Unknown status
Condition(s):Primary Sclerosing CholangitisLast Updated:February 7, 2024Recruiting
Condition(s):Primary Sclerosing CholangitisLast Updated:July 18, 2022Not yet recruiting
Condition(s):Primary Sclerosing CholangitisLast Updated:September 5, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.